VESCOVINI, Rosanna
 Distribuzione geografica
Continente #
NA - Nord America 2.231
AS - Asia 1.895
EU - Europa 1.251
SA - Sud America 233
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 5.740
Nazione #
US - Stati Uniti d'America 2.154
SG - Singapore 596
CN - Cina 487
VN - Vietnam 358
IT - Italia 263
SE - Svezia 215
IE - Irlanda 178
BR - Brasile 165
DE - Germania 153
HK - Hong Kong 148
FI - Finlandia 100
ZA - Sudafrica 86
FR - Francia 74
BD - Bangladesh 73
TR - Turchia 65
NL - Olanda 46
CA - Canada 45
UA - Ucraina 39
GB - Regno Unito 35
RU - Federazione Russa 33
IN - India 31
AR - Argentina 30
AT - Austria 20
BE - Belgio 19
JP - Giappone 18
CI - Costa d'Avorio 16
IQ - Iraq 15
MX - Messico 15
RO - Romania 15
KR - Corea 14
PH - Filippine 13
PL - Polonia 12
CZ - Repubblica Ceca 11
ES - Italia 11
EC - Ecuador 9
PK - Pakistan 9
TH - Thailandia 8
CO - Colombia 7
ID - Indonesia 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
PA - Panama 6
PY - Paraguay 6
PE - Perù 5
UZ - Uzbekistan 5
AL - Albania 4
AZ - Azerbaigian 4
EG - Egitto 4
ET - Etiopia 4
IL - Israele 4
PT - Portogallo 4
TW - Taiwan 4
VE - Venezuela 4
AM - Armenia 3
BO - Bolivia 3
CH - Svizzera 3
EU - Europa 3
IR - Iran 3
JO - Giordania 3
SA - Arabia Saudita 3
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
AQ - Antartide 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
Totale 5.737
Città #
Singapore 312
Ashburn 306
San Jose 236
Chandler 209
Dublin 177
Dallas 160
Santa Clara 140
Hong Kong 133
Ho Chi Minh City 109
Hanoi 98
Beijing 90
Los Angeles 79
Parma 79
Johannesburg 78
Boardman 69
New York 64
Dearborn 61
Jacksonville 59
Munich 58
Shanghai 57
Ann Arbor 54
Lauterbourg 41
Nanjing 41
Izmir 39
Hefei 30
Princeton 30
Buffalo 26
Toronto 24
Wilmington 23
Shenyang 21
Council Bluffs 20
Brussels 19
Milan 19
Vienna 19
Kocaeli 18
Columbus 17
Da Nang 17
Helsinki 17
San Mateo 17
Abidjan 16
Kunming 16
Bologna 15
Bremen 15
Moscow 15
Turku 15
São Paulo 14
Tokyo 14
Marseille 13
Düsseldorf 12
Haiphong 12
The Dalles 12
Denver 11
Jinan 11
Woodbridge 11
Atlanta 10
Hebei 10
Rome 10
Warsaw 10
Brno 9
Chicago 9
Des Moines 9
Montreal 9
Nanchang 9
Redmond 9
Tianjin 9
Brooklyn 8
Changsha 8
Frankfurt am Main 8
Baghdad 7
Houston 7
London 7
Stockholm 7
Biên Hòa 6
Focsani 6
Jakarta 6
Poplar 6
Seoul 6
Amsterdam 5
Can Tho 5
Charlotte 5
Jiaxing 5
Modena 5
Orem 5
Phoenix 5
San Francisco 5
Tashkent 5
Addis Ababa 4
Ankara 4
Basingstoke 4
Belo Horizonte 4
Casablanca 4
Dhaka 4
Dubai 4
Erbil 4
Lahore 4
Norwalk 4
Pune 4
Reggio Emilia 4
Savignano sul Rubicone 4
Zhengzhou 4
Totale 3.554
Nome #
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 220
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 215
Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis 201
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients 196
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 196
A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis. 189
Impact of persistent cytomegalovirus infection on dynamic changes in human immune system profile 186
The dynamics of circulating T cell subsets in CMV infected and non-infected subjects. 183
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 182
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 182
MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study 182
Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells 179
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 174
Human cytomegalovirus infection in an as yet unexplored at-risk category of subjects: elderly subjects facing acute ischemic stroke 169
Variability of CD8+ T Cells Subversion According to Age and Antigen-specific Responses to Cytomegalovirus in Later Life. 161
Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status 159
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 157
Human cytomegalovirus infection in an unexplored "at risk" category of subjects. 156
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 154
HCMV infection and clinical outcomes in Stroke patients. 153
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 151
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 146
Thrombotic thrombocytopenic purpura with severe neurologicalimpairment: remission after Rituximab. 139
CD38 expression by plasma cells in extramedullary multiple myeloma 138
The impact of CD56 expression in smoldering myeloma patients on early progression 137
Expansion of cytotoxic CD8+, CD28- cells in healthy ageing people, including centenarians. 127
HCMV infection, inflammation and age-related diseases: a dangerous association 122
The immune system in extreme longevity 121
High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease 119
T cell dynamics in aginmg: relationship between loss of CD95- and increase of CD28- T cells, Third Eur. Congr. Geriatr., Catania 2001, Abs Book p. 118 116
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients 115
T-cell dynamics in aging: studies on antigen and cytokine-specific CD8+ T cell subset in humans. III Int. Conf. on basic biology and clinical impact on immunosenescence. Palermo, aprile 2002. Abs p.31 115
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 113
Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects 112
T-lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians, 103
Report from the Second Cytomegalovirus and Immunosenescence Workshop. 97
Pygo2 Is Overexpressed in Myeloma Cells With 1q21 Amplification Being Involved in Carfilzomib Resistance 90
Preliminary evaluation of the factors affecting lymphocytes in peripheral blood and endometrial tissue of ovariohysterectomized bitch 53
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape 50
FROM PRECURSOR DISEASES TO MULTIPLE MYELOMA: REMODELING OF THE OSTEOBLASTIC NICHE AT SINGLE CELL RESOLUTION 26
TARGETING GLUTAMINE METABOLISM POTENTIATES T CELL ENGAGER–MEDIATED IMMUNOTHERAPY IN MULTIPLE MYELOMA 19
Totale 5.803
Categoria #
all - tutte 18.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.087


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022194 16 5 6 16 10 6 21 24 8 11 12 59
2022/2023781 83 96 64 48 72 81 29 46 214 13 21 14
2023/2024325 18 24 7 9 25 81 34 25 7 18 20 57
2024/2025972 21 38 47 90 79 105 68 35 129 90 95 175
2025/20262.702 218 178 321 249 342 176 323 119 321 223 143 89
Totale 5.803